Thank you Commissioner @OliverVarhelyi for supporting #EuropeanLiverScreeningWeek
Today is also #WorldHeartDay liver & heart health are deeply connected
With simple testing, we can detect #LiverDisease early, reduce #CVD risk & save lives
#LiverHealth #EU4Health #MASLD #MASH #Hepatitis #LiverCancer
Next week: the final DECISION General Assembly in Madrid! 🎉
Celebrating 5+ years of science, collaboration, & results
@rautoupe.bsky.social @concentris.bsky.social
@navarrabiomed.bsky.social
@bioeticayderecho.bsky.social
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social et al
💜 October is Liver Cancer Awareness Month💜
The liver performs over 500 vital functions every single day to keep us alive — from cleansing blood to storing vitamins. Yet, liver cancer often develops silently in a damaged liver, with no symptoms in the early stages.
💚 Our liver and mind are deeply connected.💚
Living with chronic liver disease, #hepatitis B, C, or D, #livercancer, #MASLD, #MASH, #alcohol-related liver disease, or rare conditions like #Alpha-1, #PBC, #PSC, or #LALD... can impact not only the body — but also mental and emotional well-being.
💪 Together, we can stop liver cancer before it starts! 💛
Prevention begins with awareness and awareness begins with you.
By tackling known risk factors like hepatitis infections, alcohol misuse, fatty liver disease, and obesity, we can turn the tide against one of Europe’s fastest-rising cancers
www.theparliamentmagazine.eu/partner/arti...
👉 Together, we raise awareness, protect lives, and take action for a healthier future.
Join us and be part of this movement!
🌍💪 #LiverScreeningWeek
#Obesity #MASLD #MASH #Hepatitis B,C and D #Alcohol #RareLiverDisease #EUCancerPlan #NCDs #CardiovascularDisease
#LiverCancerAwarenessMonth
🩺 The Liveraim Padua team joined #DiSaluteWeekend 💙
✅Free elastography for the community
✅Awareness on chronic liver disease prevention
👉 Prevention saves lives!
#LiverHealth #Prevention #PublicHealth
@ihieurope.bsky.social @easlnews.bsky.social @unipd.bsky.social
Milan Mishkovikj, director of the European Liver Patients' Association, has this to say about IHI collaborative patient research: "This research is a beacon of hope, empowering individuals and transforming lives and systems. It reminds us that through collaboration, innovation and compassion, we can overcome challenges and create a world where liver health is not just a dream but a reality for all."
👋 Happy Monday! This week, we're focusing on #PatientsInResearch. ⚡ Our projects seek to involve patients in decision-making from the earliest stages, because #CollaborativeResearch brings the best results! Read what @mkdmilan.bsky.social, director of @europeliver.bsky.social, has to say:
🇪🇺 ELPA + EU Parliament = action.🩺 From MASLD & hepatitis to rare liver disease—millions are at risk.
⚠️ 60% preventable with early detection.
💙 European Liver Screening Week, under the EU Parliament’s patronage.
#LiverHealth #EU
📢 Prevention. Early detection. Change.
#PreventionSavesLives
Want to know more about patient engagement in our projects? Read more about it here: europa.eu/!FwJk7T
💚 September is Primary Biliary Cholangitis (PBC) Awareness Month!
On September 14, 2025, we mark PBC Awareness Day — a day to shine a light on this rare autoimmune liver disease. Together, we raise awareness, support patients, and spread hope across Europe
#PBCmonth, we raise our voices for every person living with Primary Biliary Cholangitis
Thanks to medical and scientific progress, new treatments have been approved & are bringing hope to thousands of patients. But we need more – we need #equal access and #reimbursement across all European countries
🌍💚 Knowledge is Power – Together We Fight PBC!💚🌍
Early diagnosis of Primary Biliary Cholangitis (PBC) saves lives. With just two simple criteria, doctors can detect and patients can take control of their health journey.
💡 Raise awareness. Share knowledge. Empower patients.
A clear diagnosis is the first step toward better care. 💚
With simple blood tests for AMA and ALP, doctors can confirm Primary Biliary Cholangitis early — no biopsy needed in most cases.
Early detection means stronger treatment, brighter tomorrows, and more hope for patients worldwide.
From Policy to Practice: The Role of #LiverHealth in #EU #CVD & #CancerPlans
The Missing Piece in Cardiovascular Prevention: #LiverHealth!
A huge thank you to Commissioner Várhelyi for recognizing the vital role of liver health in prevention and care. #EuropeanLiverScreeningWeek
#EASD2025 in Vienna, ELPA President Marko Korenjak joined the Arena Lab Talks to show what real innovation looks like: patients + researchers shaping the future of care
🔹 Screening & early detection first
🔹 Real-world data > stats alone
🔹 End stigma lead with compassion & evidence
🔹 Integrated care
🚨 The future of liver healthcare is here! 🌍🧬
Watch how ARTEMIS EU Project uses virtual twins to fight #MASLD, a disease affecting 1 in 4 Europeans.
🎥 youtu.be/SW1rIpcZcI8
With top scientists, clinicians & ELPA, we’re shaping personalized liver care. 💡✨
#LiverHealth
🚨 Revolutionizing liver healthcare! ARTEMIS is using virtual twins & digital modeling to fight #MASLD and improve patient lives. 🌍💡✨ #InnovationInMedicine #LiverHealth
💡 Did you know?
ARTEMIS Work Package 9 focuses on exploitation & sustainability – protecting intellectual property, promoting project results, and ensuring long-term impact.
#Innovation #Sustainability #ARTEMISEU
Did you know?
One of ARTEMIS’ clinical cases studies fibrosis progression in #MASLD patients. The goal: predict outcomes such as transplant needs, liver failure, or cancer – and improve patient care.
#LiverHealth #InnovationInMedicine
💡 Did you know?
ARTEMIS Clinical Case 2 explores fibrosis-associated heart failure patients, focusing on predicting incidence events in MASLD and evaluating the impact of hepatic fibrosis and MASH on early cardiovascular risk.
#LiverHealth #CardioRisk #ARTEMISEU
💡 Did you know?
ARTEMIS Clinical Case 3 investigates cardiovascular complications after TIPS placement, predicting cardiovascular events and evaluating overall survival and cirrhosis outcomes.
#LiverHealth #PortalHypertension #ARTEMISEU
Proud to be at the high-level policy event – Connecting the Dots: Obesity, Digestive Diseases, and Cancers - Milan Mishkovikj
@mkdmilan.bsky.social
oncodaily.com/blog/milan-m...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Ending the Silent Epidemic of Fatty Liver Disease and Addressing Its Deadly Ties to NCDs - Milan Mishkovikj
@mkdmilan.bsky.social
oncodaily.com/blog/fatty-l...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FattyLiverDisease #NCDs #FattyLiverDay #FattyLiverMonth
@liveraim.bsky.social @jvlazarus.bsky.social @korenjak.bsky.social @mkdmilan.bsky.social @ihieurope.bsky.social @euonehealth.bsky.social
